Observed Signal · Jun 15, 2026 · Market Signal · Source: .406 Ventures · Impact: 4/5

InStride Announces $30M in Series C Funding

Executive Signal Summary

InStride, the most trusted, insurance-covered specialty program for young people living with complex anxiety, OCD, and related disorders, raised a $30M Series C from new strategic investors Echo Health Ventures and FMZ Ventures, with continued participation from existing backers: .406 Ventures, Valtruis, General Catalyst, and Mass General Brigham Ventures.

SIGNAL RADAR

Track .406 Ventures Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.

Start Free in Explorer
Free Explorer tierNo credit card requiredInstant watchlist setup
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: .406 Ventures•Published: Jun 15, 2026

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

Track Real-Time Market Signals & Shifts

Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.